Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
nitisinone
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2002 |
| gptkbp:ATCCode |
A16AX04
|
| gptkbp:CASNumber |
104206-65-7
|
| gptkbp:chemicalFormula |
C14H10F3NO5S
|
| gptkbp:form |
capsule
oral suspension |
| https://www.w3.org/2000/01/rdf-schema#label |
Orfadin
|
| gptkbp:KEGGID |
D08213
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Swedish Orphan Biovitrum
|
| gptkbp:mechanismOfAction |
4-hydroxyphenylpyruvate dioxygenase inhibitor
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
4464
DB00661 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
thrombocytopenia
leukopenia photophobia keratitis ocular symptoms |
| gptkbp:UNII |
8ECV5P0K1J
|
| gptkbp:usedFor |
hereditary tyrosinemia type 1
|
| gptkbp:bfsParent |
gptkb:Sobi
|
| gptkbp:bfsLayer |
7
|